Carbonic anhydrases (CAs) are zinc metalloenyzmes that catalyze the reversible conversion of carbon dioxide to carbonic acid and are involved in respiration, calcification, acid-base balance, and formation of fluids. Transcriptional profiling of the developing neonatal mouse uterus detected expression of Car1, Car2, Car11, and Car13 between Postnatal Days (PNDs) 3 and 18. In the neonatal mouse uterus, Car2 and Car11 mRNAs were predominantly localized in endometrial epithelial and stromal cells, respectively, whereas Car13 mRNA was detected in both epithelia and stroma. CAR2 protein was detected primarily in the endometrial epithelia and from PND 3 to PND 18 in the uteri of neonatal mice. To determine whether CA regulated uterine development, neonatal mice were treated s.c. with acetazolamide, a CA inhibitor, from PND 3 to PND 18. Treatment with acetazolamide decreased CA activity in the uterus and the number of endometrial glands without apparent effects on differentiation of the stroma or myometrium. In the neonatal sheep uterus, CA2 mRNA was initially expressed at birth (PND 0) in the endometrial luminal epithelium and was predominantly expressed in the developing glandular epithelium from PND 7 to PND 56. These results support the hypothesis that CA has a functional role in endometrial gland development during postnatal uterine morphogenesis.
INTRODUCTION
Carbonic anhydrases (CAs) are zinc metalloenzymes that catalyze the reversible hydration-dehydration of carbon dioxide and bicarbonate [1] . Among human CAs, several active isozymes, acatalytic isozymes, and CA-related proteins have been identified, and the CA gene family continues to increase in number [2] . At least 11 members of the CA family identified at present, with CA2 being the most abundant and most efficient enzyme [1] . The known enzymes differ in their kinetic properties, subcellular localization, and tissue-specific distribution [1] . CAs appear to have a role in diverse physiological and biological processes including respiration, acid-base balance, ion transport, bone absorption, renal acidification, gluconeogenesis, and ure- agenesis as well as the formation of aqueous humor, cerebrospinal fluid, saliva, and gastric acid [1, 3] .
Carbonic anhydrases are involved in many aspects of reproduction and have a functional role in sperm maturation and capacitation by influencing bicarbonate secretion [4, 5] . Inhibition of CA activity with acetazolamide (ACTZ) inhibited acidification of epididymal fluid [6, 7] , decreased fluid secretion in the testis, and impaired sperm function [8, 9] . In rabbits, CA activity in the uterus is related to plasma progesterone levels [10, 11] . Direct distillation of ACTZ into the rabbit uterine lumen prevented pregnancy [11] , likely by preventing secretion of bicarbonate by the endometrial epithelia [12] . In the human uterus, CA12 is abundantly expressed in the endometrial epithelia [13] . In the neonatal mouse uterus, several members of the CA family are expressed during postnatal development [14] . However, the role of CAs in uterine development and morphogenesis has not been investigated.
The mature uterus consists of two functional compartments, the endometrium and myometrium [15] . The endometrium is the inner mucosal lining of the uterus, consisting of two epithelial cell types: luminal epithelium (LE) and glandular epithelium (GE), and stroma [16, 17] . The myometrium is the smooth muscle component of the uterine wall and has two layers, an inner circular and an outer longitudinal layer. Although uterine development begins in the fetus, it is not completed until after birth. Postnatal uterine morphogenesis involves the differentiation and development of the endometrial GE from the LE as well as the endometrial stroma and inner circular and outer longitudinal layers of the myometrium from the uterine mesenchyme [18, 19] . Endometrial gland development, also termed adenogenesis, is principally a postnatal process in all mammals. Endometrial glands and their secretions are critical regulators of peri-implantation embryo survival and implantation as well as establishment of uterine receptivity [20] [21] [22] [23] . Therefore, it is important to understand the hormonal, cellular, and molecular mechanisms regulating postnatal development of the uterus. In mice, postnatal development of the endometrial glands is initiated between birth (Postnatal Day, or PND 0) and PND 5, and is essentially complete by PND 15 [14, 24] . In sheep, endometrial gland genesis is initiated between PND 0 and PND 7, when shallow epithelial invaginations appear along the LE in presumptive intercaruncular areas [25] . Nascent GE buds proliferate and invaginate into the stroma between PNDs 7 and 14, forming tubular structures that coil and branch by PND 21. By PND 56, the caruncular and intercaruncular endometrial areas are histoarchitecturally similar to those of the adult uterus. Little is known of the mechanisms regulating postnatal uterine morphogenesis and, in particular, endometrial gland development.
Interesting similarities exist between endometrial gland 132 HU AND SPENCER development and tumor cell invasion. Numerous studies indicate that the environment of tumor cells generally is more acidic than that of normal cells [26] . Many tumor cell types specifically express different members of the CA family, suggesting their involvement in acidification and cell invasion [27, 28] . Indeed, inhibition of CA activity with ACTZ prevents tumor cell invasion [29] . Because CA activity is associated with endometrial gland proliferation in the rabbit [11] and Car2 null mice appear to lack endometrial glands [30] , our working hypothesis is that CAs have a functional role in endometrial gland development in the postnatal uterus. Therefore, our objectives were as follows: 1) to determine the ontogeny of Car expression in the neonatal mouse uterus, 2) discern the role of CA in neonatal mouse uterine development, and 3) determine whether CA2 mRNA is expressed in the developing neonatal sheep uterus.
MATERIALS AND METHODS

Mouse Uterine Tissue Collection and CodeLink Microarray Analysis
The University Laboratory Animal Care and Use Committee of Texas A&M University approved all experimental procedures. Adult virgin CD-1 female mice were obtained from Charles River Laboratories (Wilmington, MA) and mated with fertile males of the same strain to establish pregnancy. All mice were housed in a temperature-controlled room (21 to 22ЊC) in a 12L:12D cycle in the Kleberg Center Mouse Facility (Texas A&M University) and provided fresh reverse osmosis/deionized water and NIH-31 lab chow ad libitum.
In study 1, uteri were obtained from mice from different litters on PNDs 3, 6, 9, 12, or 15 (n Ն 20 per day). Portions of each uterine horn were fixed in 4% (w/v) paraformaldehyde in PBS (pH 7.2). The remainder of the uterine horns were snap-frozen in liquid nitrogen and stored at Ϫ80ЊC for RNA or protein extraction. After 24 h, fixed tissues were changed to 70% ethanol and then embedded in Paraplast Plus (Oxford Labware, St. Louis, MO).
In study 2, epithelial and stromal/myometrial cells were isolated from PND 3, 6, and 9 (n Ն 10 per day) mouse uteri by enzymatic digestion as described previously [14] . Total RNA was extracted from either the entire uterus on each PND or separated epithelia and stroma/myometrium using Trizol reagent (Gibco-BRL, Bethesda, MD). Transcriptional profiling was conducted using total RNA and a CodeLink UniSet Mouse I Expression Bioarray (Amersham Biosciences, Piscataway, NJ) by the genomics core facility of the Texas A&M University National Institute of Environmental Health Sciences Center for Environmental and Rural Health as described previously [14] .
Sheep Uterine Tissue Collection
In study 3, crossbred Spring-born Suffolk ewes (n ϭ 45) were assigned randomly at birth (PND 0) to be hysterectomized on PND 0 (n ϭ 6), 7 (n ϭ 4), 14 (n ϭ 5), 21 (n ϭ 5), 28 (n ϭ 5), 35 (n ϭ 5), 42 (n ϭ 5), 49 (n ϭ 5), or 56 (n ϭ 5). At hysterectomy, the entire reproductive tract was excised, and the uterus was trimmed free of the broad ligament, oviduct, and cervix. Each uterine horn was fixed in 4% (w/v) paraformaldehyde in PBS (pH 7.2). After 24 h, fixed tissues were changed to 70% ethanol and then embedded in Paraplast Plus.
Effect of ACTZ Treatment on Uterine CA Activity and Development in Neonatal Mice
Acetazolamide (Sigma Chemical Co., St. Louis, MO) was dissolved in dimethylsulfoxide (DMSO) and corn oil vehicle (final DMSO concentration was 10%). In study 4, female mice were randomly assigned to receive daily s.c. injections of ACTZ at a dose of either 0, 25, 50, or 250 mg/kg body weight in vehicle from PND 3 to PND 18 (n ϭ 8 mice per treatment group). Mice were weighed daily before injections to adjust for growth. Treatments were administered in a final volume of ϳ20 l from PND 3 to PND 9 and ϳ50 l from PND 10 to PND 18. Uteri were collected 6 h after last injection on PND 18 and then frozen in liquid nitrogen and stored at Ϫ80ЊC for assay of CA activity.
In study 5, female mice were assigned randomly (n ϭ 8 mice per treatment group) to remain uninjected as a control or to receive daily s.c. injections of ACTZ at a dose of either 0, 25, 50, or 250 mg/kg body weight from PND 3 to PND 18 as described in study 4. Uteri were collected 6 h after last injection on PND 18, and body weight and uterine wet weights were measured and recorded. Uteri from control or ACTZtreated mice were fixed in 4% paraformaldehyde and embedded in Paraplast Plus. Cross-sections (n ϭ 6) of each uterus were prepared (5 m) and stained with hematoxylin. Endometrial gland number was determined by counting the total number of glands in a complete cross-section of the uterine horn using methods similar to those described previously [31] . Gland number estimates were generated for at least six nonsequential sections from each uterus. Data are presented as total gland number per uterine horn cross-section.
In Situ Hybridization Analysis
Partial cDNAs for ovine CA2 and mouse Car1, Car2, Car11, and Car13 mRNAs were cloned by reverse transcription-polymerase chain reaction as described previously [25] . The amplified partial cDNAs were cloned into pCRII vector using a TA cloning kit (Invitrogen, Carlsbad, CA) and sequenced to confirm identity. In situ hybridization was conducted on cross-sections of the mouse (study 1) and ovine uterus (study 3) as described previously [32] . Briefly, antisense and sense radiolabeled cRNA probes were generated using appropriate polymerases by in vitro transcription with [␣-35 S]UTP. Transcripts protected from RNase digestion were visualized by liquid emulsion autoradiography using NTB-2 (Kodak, Rochester, NY). Slides were stored at 4ЊC for several weeks as judged from autoradiographs, developed in Kodak D-19 developer, and counterstained with hematoxylin.
Western Blot Analysis
Total protein extracts of pooled mouse uteri (n ϭ 3 separate pools per PND) from study 1 were prepared by homogenizing the uterus in extraction buffer (60 mM Tris pH 7.0, 1 mM Na 3 VO 4 , 10% glycerol, 2% SDS, and 1ϫ protease inhibitor cocktail from Roche, Indianapolis, IN). Proteins extracted from adult uteri from mice in estrus were used as a positive control. Protein content of uterine extracts was determined using the DC protein assay (Bio-Rad, Hercules, CA) with BSA as the standard. Total protein (30 g) from uterine extracts was denatured and separated by 10% SDS-PAGE, and Western blot analysis was conducted as described previously [33] . Immunoreactive CAR2 protein was detected using polyclonal rabbit antiserum generated against mouse CAR2 (kindly provided by Dr. William Sly, Washington University School of Medicine, St. Louis, MO) at a 1:10 000 final dilution. Negative control blots were performed in which primary antiserum was replaced by nonimmune rabbit serum at the same concentration. As an internal control to correct for differences in protein loading, blots were reprobed with mouse anticytochrome C immunoglobulin G (65981A; Pharmingen, San Diego, CA) at a 1:10 000 final dilution. Immunoreactive proteins were detected by chemiluminescence (SuperSignal West Pico, Pierce, Rockford, IL) according to the manufacturer's recommendations using X-OMAT AR x-ray film (Kodak). Western blots were quantified by scanning densitometry using a Bio-Rad GS-690 imaging densitometer and Multi-Analyst Software.
Immunohistochemistry
Immunohistochemical localization of CAR2 protein in the mouse uterus was performed as described previously [25] in mouse uteri from study 1. After antigen retrieval using a boiling citrate buffer, uterine sections (at least three sections per mouse) were washed and endogenous peroxidase activity was inactivated by incubating with 3% hydrogen peroxide in methanol. Rabbit anti-mouse CAR2 serum or nonimmune rabbit serum was used at a 1:1000 final dilution. The chromagen used for peroxidase localization was 3,3Ј-diaminobenzidine tetrahydrochloride (Sigma), and the slides were not counterstained.
Measurements of CA Activity
Mouse uteri from study 4 were pooled within treatment and then homogenized in 50 mM Hepes buffer containing 1ϫ protease inhibitor cocktail (Roche) for determination of CA activity, which was performed essentially as described by Miyamoto et al. [34] . Protein content of uterine extracts was determined using the Bio-Rad DC protein assay with BSA as the standard. Briefly, 3 ml of ice-cold Veronal buffer (pH 8.3) was mixed with 150 l of 1% phenol red and 20 l of sample (ϳ60 g total protein) or buffer as a negative control in a glass tube with a stopper. After incubation on ice for 5 min, 2 ml of ice-cold CO 2 -saturated water was added to the mix, and the tube was quickly inverted. The time (in seconds) for the color to change from red to yellow (pH 6.3) was recorded and compared with the time for standards. All the samples were assayed in triplicate, and the entire assay was repeated at least three times. The intraassay coefficient of variation (CV) was 4.9%, and the interassay CV was 7.2%.
Photomicroscopy
Representative photomicrographs of uteri were taken using a Nikon Eclipse 1000 photomicroscope (Nikon Instruments Inc., Lewisville, TX) under brightfield or darkfield illumination (or both) and captured using a Nikon DXM1200 digital camera.
Statistical Analysis
All quantitative data were subjected to least-squares analysis of variance (LS-ANOVA) using the General Linear Models procedures of the Statistical Analysis System version 8.1 for Windows (SAS Institute, Cary, NC). For Western blot analyses of CAR2, integrated optical density measurements were analyzing using a model that incorporated PND and replicate as the sources of variation. The measurement of band optical density for cytochrome C was used as a covariate. The data for uterine CA activity measurements were analyzed by least squares regression analysis. In these analyses, time was considered a continuous, independent source of variation with replicate as a dependent source. Statistical models for analysis of morphometry data included main effects of treatment, mouse within treatment, tissue section, and the appropriate interactions. Initial analyses indicated that tissue section was not a significant source of variation. Data are presented as least square means with overall standard errors (SEM).
RESULTS
Expression of CA in the Mouse Uterus
The normalized expression level of different CA family members in uteri from neonatal mice (study 1) and separated uterine cell populations (epithelium and stroma/myometrium) from neonatal mice (study 2) are summarized in Tables 1 and 2 , respectively, as determined by microarray analysis. Expression of Car1, Car2, Car11, and Car13 mRNAs was detected in all neonatal mouse uteri. Cell separation analyses indicated that Car2 and Car13 mRNAs were expressed most abundantly in the endometrial epithelium, whereas Car11 mRNA was expressed predominantly in the stroma and myometrium.
Localization of Car mRNA Expression in Neonatal Uteri from Mice and Sheep
In the uterus of neonatal mice, Car2 and Car11 mRNAs were detected predominantly in endometrial epithelium and stroma, respectively, but not in the myometrium (Fig. 1) . However, Car13 mRNA was detected in all uterine cell types (Fig. 1B) . Expression of Car1 mRNA was below the limits of detection by in situ hybridization (data not shown).
In the uterus of neonatal sheep (study 3), CA2 mRNA was detected in the endometrial LE on PND 0, but was present predominantly in the endometrial GE from PNDs 7 to 56 (Fig. 2) . Expression of CA2 mRNA was not observed in the endometrial stroma or myometrium. The melanocytes in the PND 14 and PND 49 uteri are not positive for CA2 mRNA, but contain melanin pigment that appears white under darkfield illumination.
CAR2 in the Neonatal Mouse Uterus
Car2 was the most abundant member of the CA family expressed in the neonatal mouse uterus (Tables 1 and 2 observed in Western blot analyses of whole uterine extracts (Fig. 3A) . The overall abundance of CAR2 protein in the mouse uterus increased (quadratic, P Ͻ 0.05) ϳ2-fold from PND 3 to PND 18 (Fig. 3B) . The uteri from adult mice in estrus were used as a positive control.
In the developing neonatal mouse uterus, immunoreactive CAR2 protein was observed predominantly in the cytoplasm of the endometrial epithelia of the endometrium with lower levels in the stroma, depending on the day (Fig.  4) . On PND 3, CAR2 protein was most abundant in the endometrial LE based on comparison with negative controls in which nonimmune rabbit serum was used in place of the rabbit anti-mouse CAR2 serum. On PNDs 6 and 9, CAR2 protein remained most abundant in the endometrial LE and nascent GE, but was also observed in the stroma, albeit at lower abundance. Between PNDs 9 and 12, the abundance of CAR2 protein increased in the endometrial LE and GE, but not in the stroma. No immunoreactive CAR2 protein was observed in the myometrium on any PND.
Effect of ACTZ on Uterine CA Activity and Development in the Neonatal Mouse
In study 4, treatment of neonatal mice with ACTZ, a specific inhibitor of CA activity [35] , from PND 3 to PND 18, decreased uterine CA activity on PND 18 in a dosedependent manner (linear, P Ͻ 0.01) as indicated by the increase in time required for the pH to decrease from 8.3 to 6.3 in the CA activity assay (Fig. 5) . At a dose of 50 and 250 mg/kg, the time required was not different (P Ͼ 0.10) from that of adding buffer alone, signifying complete inhibition of uterine CA activity.
In study 5, neonatal mice were treated with ACTZ from PND 3 to PND 18. No toxic effects of ACTZ were observed in the neonatal mice regardless of dose. Treatment with vehicle alone decreased (P Ͻ 0.05) body weight and uterine wet weight relative to untreated controls (data not shown). However, uterine wet weight was not different (P Ͼ 0.10) among the ACTZ treatment groups if body weight was used as a covariate in the statistical analyses (data not shown). Treatment of neonatal mice with ACTZ appeared to specifically retard development of the endometrial glands without affecting development of the stroma or myometrium (Fig. 6A) . Morphometrical analyses indicated that endometrial gland number was decreased (P Ͻ 0.01) in mice treated with ACTZ (25, 50, and 250 mg doses) compared with that in mice receiving the vehicle alone (0 mg dose) or in those left untreated as a control (Fig. 6B ).
DISCUSSION
Although CA activity has been detected in uterine endometrium of various mammals [11] , which members of CA exist in the uterus and their roles in uterine function have not been well investigated. Our microarray data indicated that Car1, Car2, Car11, and Car13 were the most abundant members of the CA family expressed in the neonatal mouse uterus. In situ hybridization analysis indicated that Car2 and Car11 mRNAs were predominantly localized in the mouse uterine epithelium and stroma, respectively.
In the neonatal sheep uterus, CA2 mRNA was also expressed in developing endometrial glands. The temporal and spatial alterations in uterine CA2 expression suggested a biological role in endometrial gland development during postnatal uterine morphogenesis.
Microarray analyses found that Car2 was predominantly expressed in the endometrial LE of the neonatal mouse uterus, which was confirmed by in situ hybridization and immunohistochemical analyses. Although Car2 mRNA increased approximately 3-fold in the endometrial LE between PNDs 3 and 6, CAR2 protein abundance did not exhibit the same relative increase until between PNDs 9 and 12 as determined by immunohistochemical analyses. Further, relative levels of CAR2 in the whole uterus did not increase until after PND 9 as determined by Western blot analyses. The discordance in Car2 mRNA and CAR2 protein levels could be due to posttranscriptional regulation through effects on mRNA or protein stability.
Treatment of neonatal mice with ACTZ, a CA inhibitor, decreased pup growth, as indicated by a reduction in body weight, but ACTZ was not toxic. The reduction in pup growth was likely due to the DMSO vehicle, which is an organic solvent that can inhibit cell growth in vitro [36] . Alternatively, daily handling of the pups might also inhibit their growth. Systemic application of ACTZ at doses ranging from 5 to 50 mg/kg body weight specifically inhibited CA activity without side effects depending on the organ tested [37] . Chronic application of ACTZ for 2 wk in rats is required to affect the morphology of the renal collecting ducts, but it does not affect systemic and urinary biological parameters [38] . The acute effect of ACTZ is the loss of sodium and bicarbonate in urine, which becomes self-limiting after chronic administration of ACTZ [38] .
In the present study, treatment of neonatal female mice from PND 3 to PND 18 inhibited uterine CA activity and decreased the total number of endometrial glands at PND 18, indicating that CAs have a functional role in endometrial gland development during postnatal uterine morphogenesis. Although a significant inhibition of uterine CA activity was not achieved at the 25 mg dose, treatment of neonatal mice with the 25 mg dose did inhibit endometrial gland development. One possibility is that the assay used to measure uterine CA activity was not sensitive enough to detect ACTZ effects on uterine CA activity at the 25 mg dose. Other possibilities include differences in threshold effects of ACTZ on CA activity as compared to a biological endpoint (e.g., uterine gland development). Finally, different CA family members may exhibit differential sensitivity to inhibition by ACTZ. However, the present data agree with a report that Car2 null mice lack endometrial glands [30] . Of interest, CAR2 was the most abundantly expressed member of the family in the neonatal mouse uterus and was specifically expressed in the endometrial epithelia of both the neonatal mouse and sheep uterus. These findings suggest a specific role for CA2 in uterine gland development and perhaps function across species.
The mechanism of how CAR2 regulates endometrial adenogenesis during postnatal uterine morphogenesis is not known. Many tumor cell types specifically express different members of the CA family, and the environment of tumor cells generally is more acidic [26] , suggesting the involvement of CA in acidification and cell invasion [27, 28] . In support of this notion, a combination of ACTZ treatment with chemotherapy further delayed tumor growth in vivo compared with chemotherapy alone [39] . Inhibition of CA activity prevented tumor cell invasion in vitro by modifying the extracellular pH [29] or through disturbing E-cadherinmediated cell adhesion [40] . Human melanoma cells cultured at acidic pH secreted more active matrix metalloproteinase 9 (MMP-9) into the medium and are more invasive than cells cultured in neutral pH [40] . Further, increased CA9 activity was associated with enhanced Matrigel invasion of human colon carcinoma cells [40] . Due to the similarities in the processes of tumor cell invasion and endometrial gland development, as well as expression of MMPs and E-cadherin in mouse uteri [41] , it can be hypothesized that CA play a key role in regulating uterine adenogenesis by affecting GE cell migration, MMP activity, or both. Indeed, MMPs and their inhibitors are involved in postnatal uterine morphogenesis in the mouse [41] [42] [43] and increased MMP activity would facilitate reorganization of extracellular matrix necessary for endometrial gland development. Further, CAs are expressed in the endometrium of the human uterus [13] , which undergoes cyclical shedding and regrowth of the endometrial glands during the menstrual cycle [44] . Thus, CAs may have a biological role in uterine morphogenesis and, in particular, endometrial gland development in a number of different mammals.
